# Adma Biologics, Inc.: Form 8-K, filed Mar 10, 2023

- Company: [Adma Biologics, Inc.](/companies/adma.md) (CIK 1368514)
- Form: 8-K
- Filed: 2023-03-10
- Accepted by EDGAR: Mar 10, 2023, 16:50 ET
- Period: 2023-03-06
- Accession: 0001140361-23-011200
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1368514/000114036123011200/brhc10049580_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1368514/000114036123011200/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1368514/000114036123011200/brhc10049580_8k.htm

Filed Mar 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-011200. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
